Aurobindo Pharma Heads to Goldman Sachs Asia Leaders Conference

Aurobindo Pharma has announced that it will attend the Goldman Sachs Asia Leaders Conference in Hong Kong on September 1-2, 2026.

The company's officials are scheduled for one-on-one and group meetings with investors and analysts. No unpublished price-sensitive information (UPSI) is intended to be discussed during these interactions.

The schedule remains subject to change due to exigencies on the part of the investor or the company.